Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Neurol Clin. 2013 Feb 19;31(2):491–510. doi: 10.1016/j.ncl.2013.01.005

Table 5.

Guillain-Barre’ Syndrome: Dutch IVIg vs. Plasmapheresis Study (66) Compared to the North American Plasmaphersis Study (59)

Dutch North American
IVIg PE PE Control
Total patients 74 73 108 120
Improved 1 grade (4 weeks) 53% 34% 59% 39%
Days to improve 1 grade (median) 27 41 19 40
Days to grade 2 55 69 19 40
Number of multiple complications 5 6 -- --
Ventilator dependent by Week 2 27% 42% -- --